Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-29 5:26 pm Purchase | 13G | PDS BIOTECHNOLOGY CORP COM PDSB | BlackRock Inc. BLK | 1,881,438 6% | 1,881,438 (New Position) | View |
| 2021-08-27 08:48 am Sale | 13G | EDGE THERAPEUTICS INC EDGE | HIRSCHMAN ORIN | 1,275,398 4.49% | -614,602 (-32.52%) | View |
| 2021-06-21 5:02 pm Purchase | 13D | EDGE THERAPEUTICS INC EDGE | NETSCIENTIFIC PLC | 1,383,923 4.88% | 101,253 (+7.89%) | View |
| 2021-06-21 08:24 am Purchase | 13G | EDGE THERAPEUTICS INC EDGE | HIRSCHMAN ORIN | 1,890,000 6.66% | 1,890,000 (New Position) | View |
| 2020-08-21 4:30 pm Purchase | 13D | EDGE THERAPEUTICS INC EDGE | NETSCIENTIFIC PLC | 1,282,670 5.76% | 236,000 (+22.55%) | View |
| 2020-03-02 4:31 pm Purchase | 13D | EDGE THERAPEUTICS INC EDGE | NETSCIENTIFIC PLC | 1,046,670 7.21% | 1,046,670 (New Position) | View |
| 2020-02-21 4:25 pm Purchase | 13G | EDGE THERAPEUTICS INC EDGE | PEIERLS E JEFFREY | 1,008,362 6.95% | 1,008,362 (New Position) | View |